Key result
CT coronary angiography cuts MI risk ~42% in suspected angina, but not non-anginal chest pain.
RCT (n=4,146)
Randomized (post hoc subgroup analysis of the SCOT-HEART trial)
Answers are grounded in this paper and cite their sources.
OBJECTIVES: To evaluate the diagnostic and prognostic benefits of CT coronary angiography (CTCA) using the 2016 National Institute for Health and Care Excellence (NICE) guidelines for the assessment of suspected stable angina. METHODS: Post hoc analysis of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial of 4146 participants with suspected angina randomised to CTCA. Patients were dichotomised into NICE guideline-defined possible angina and non-anginal presentations. Primary (diagnostic) endpoint was diagnostic certainty of angina at 6 weeks and prognostic endpoint comprised fatal and non-fatal myocardial infarction (MI). In the possible angina cohort, CTCA did not change rates of invasive angiography (p=0.481) but markedly reduced rates of normal coronary angiography (HR 0.32 (0.19 to 0.52), p<0.001). In the non-anginal cohort, rates of invasive angiography increased (HR 1.82 (1.13 to 2.92), p=0.014) without reducing rates of normal coronary angiography (HR 0.78 (0.30 to 2.05), p=0.622). At 3.2 years of follow-up, fatal or non-fatal MI was reduced in patients with possible angina (3.2% to 1.9%%; HR 0.58 (0.34 to 0.99), p=0.045) but not in those with non-anginal symptoms (HR 0.65 (0.25 to 1.69), p=0.379). CONCLUSIONS: NICE-guided patient selection maximises the benefits of CTCA on diagnostic certainty, use of invasive coronary angiography and reductions in fatal and non-fatal myocardial infarction. Patients with non-anginal chest pain derive minimal benefit from CTCA and increase the rates of invasive investigation. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT01149590;post results.
No takes yet. Share an insight, caveat, or question.
Adamson et al. (2017) conducted an RCT in Suspected stable angina (n=4,146). CT coronary angiography (CTCA) vs. Standard care without CTCA was evaluated on Diagnostic certainty of angina at 6 weeks (primary diagnostic endpoint) and fatal or non-fatal myocardial infarction at 3.2 years (prognostic endpoint in possible angina) (HR 0.58, 95% CI 0.34-0.99, p=0.045). CT coronary angiography reduced fatal or non-fatal MI in NICE-defined possible angina but not in non-anginal chest pain.
Synapse has enriched 10 related papers. Consider them for comparative context: